PEDRO PABLO ESPAÑA YANDIOLA-rekin lankidetzan egindako argitalpenak (7)
2023
2022
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Utility of Differential White Cell Count and Cell Population Data for Ruling Out COVID-19 Infection in Patients With Community-Acquired Pneumonia
Archivos de Bronconeumologia, Vol. 58, Núm. 12, pp. 802-808
2021
-
Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia (BMC Pulmonary Medicine, (2020), 20, 1, (261), 10.1186/s12890-020-01293-6)
BMC Pulmonary Medicine
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2016
-
Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial
JAMA Internal Medicine, Vol. 176, Núm. 9, pp. 1257-1265